Maneuvering ofCS toward precision medicine for AML?
microenvironments affects their expansion capacity and their response to ruxolitinib treatment. 6Thus, an in vitro model that recreates these microenvironments in a humanized context would enable detailed studies of their underlying cross talk and help identify therapeutic vulnerabilities.
Authors
- Mattias Carlsten (ORCID: https://orcid.org/0000-0001-9815-0012)
Institutions
- Karolinska Institutet (SE)
Publication Details
- Journal
- Blood
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1182/blood.2025032403
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00